Progress in the treatment of drug-induced liver injury with natural products.

Sun, Yuan-Kai; Zhang, Ya-Fei; Xie, Li; Rong, Fan; Zhu, Xing-Yu; Xie, Jing; Zhou, Huan; Xu, Tao

Sun, Yuan-Kai; Zhang, Ya-Fei; Xie, Li; Rong, Fan; Zhu, Xing-Yu; Xie, Jing; Zhou, Huan; Xu, Tao.

Afiliação

Sun YK; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei 230032, China; Anhui Key Lab. of Bioactivity of Natural Products, Institute for Liver Diseases of Anhui Medical University, Anhui Medical University, Hefei 230032, China.
Zhang YF; Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.
Xie L; Department of Ultrasound, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, China.
Rong F; People's Hospital of Lujiang County, Anhui province, Lujiang 231500, China.
Zhu XY; National Institute of Drug Clinical Trial, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China; School of Pharmacy, Bengbu Medical College, Bengbu 233004, China.
Xie J; National Institute of Drug Clinical Trial, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China.
Zhou H; National Institute of Drug Clinical Trial, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China; School of Pharmacy, Bengbu Medical College, Bengbu 233004, China. Electronic address: zhouhuan@bbmc.edu.cn.
Xu T; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei 230032, China; Anhui Key Lab. of Bioactivity of Natural Products, Institute for Liver Diseases of Anhui Medical University, Anhui Medical University, Hefei 230032, China. Elect

Pharmacol Res ; 183: 106361, 2022 09.

Article em En | MEDLINE | ID: mdl-35882295

Assuntos

Produtos Biológicos; Doença Hepática Induzida por Substâncias e Drogas; Medicamentos de Ervas Chinesas; Acetaminofen; Produtos Biológicos/uso terapêutico; Doença Hepática Induzida por Substâncias e Drogas/tratamento farmacológico; Medicamentos de Ervas Chinesas/uso terapêutico; Humanos; Hidrogéis; Medicina Tradicional Chinesa

Palavras-chave

Baicalin (PubChem CID: 64982); Crocetin (PubChem CID: 5281232); Curcumin (PubChem CID: 969516); DILI; Ginsenoside Rg1 (PubChem CID: 441923); Glycyrrhetinic acid (PubChem CID: 3230); Hydrogel; Luteolin (PubChem CID: 5280445); Naringin (PubChem CID: 442428); Natural products; Quercetin (PubChem CID: 5280343); Resveratrol (PubChem CID: 445154); Salvianolic acid C (PubChem CID: 13991590); TCM

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Medicamentos de Ervas Chinesas / Doença Hepática Induzida por Substâncias e Drogas Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google